nach oben

Cancer Immunology, Immunotherapy

Erschienen in:

19.10.2018 | Original Article

INT-HA induces M2-like macrophage differentiation of human monocytes via TLR4-miR-935 pathway

verfasst von: Boke Zhang, Yan Du, Yiqing He, Yiwen Liu, Guoliang Zhang, Cuixia Yang, Feng Gao

Erschienen in: Cancer Immunology, Immunotherapy | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

As a major component of the microenvironment of solid tumors, tumor-associated macrophages (TAMs) facilitate tumor progression. Intermediate-sized hyaluronan (INT-HA) fragments have an immunological function in cell differentiation; however, their role in promoting the polarization of non-activated macrophages to an M2-like TAM phenotype has not been characterized, and the underlying mechanisms remain unclear. Here, we used a miRNA microarray to find that some miRNAs (especially miR-935) were differentially regulated in INT-HA-induced M2-like macrophages. According to RT-qPCR and Western blot, there was an association between miR-935 and C/EBPβ, that control the polarization of macrophages. Moreover, we found that INT-HA induced an M2-like phenotype via the TLR4 receptor. In our study, there was a negative correlation between plasma HA and miR-935 in monocytes from the peripheral blood of patients with solid tumors. There was also a negative correlation between miR-935 and M2-like macrophage markers in monocytes. These findings suggest that HA fragments interact with TLR4 and educate macrophage polarization to an M2-like phenotype via miR-935. Therefore, this study provides new insight into the role of miR-935 in INT-HA-induced M2-like polarization, and suggests a potential therapeutic target for antitumor treatment.

Nur mit Berechtigung zugänglich

Italiani P, Boraschi D (2014) From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. Front Immunol 5:514. https://doi.org/10.3389/fimmu.2014.00514 CrossRefPubMedPubMedCentral

Ruffell B, Affara NI, Coussens LM (2012) Differential macrophage programming in the tumor microenvironment. Trends Immunol 33:119–126. https://doi.org/10.1016/j.it.2011.12.001 CrossRefPubMedPubMedCentral

Cook J, Hagemann T (2013) Tumour-associated macrophages and cancer. Curr Opin Pharmacol 13:595–601. https://doi.org/10.1016/j.coph.2013.05.017 CrossRefPubMed

Spinelli FM, Vitale DL, Demarchi G et al (2015) The immunological effect of hyaluronan in tumor angiogenesis. Clin Transl Immunol 4:e52. https://doi.org/10.1038/cti.2015.35 CrossRef

Stern R, Asari AA, Sugahara KN (2006) Hyaluronan fragments: an information-rich system. Eur J Cell Biol 85:699–715. https://doi.org/10.1016/j.ejcb.2006.05.009 CrossRefPubMed

Misra S, Hascall VC, Markwald RR et al (2015) Interactions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer. Front Immunol 6:201. https://doi.org/10.3389/fimmu.2015.00201 CrossRefPubMedPubMedCentral

Laurent TC, Laurent UB, Fraser JR (1995) Functions of hyaluronan. Ann Rheum Dis 54:429–432CrossRefPubMedPubMedCentral

Tian X, Azpurua J, Hine C et al (2013) High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat. Nature 499:346–349. https://doi.org/10.1038/nature12234 CrossRefPubMedPubMedCentral

Termeer CC, Hennies J, Voith U et al (2000) Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol 165:1863–1870CrossRefPubMed

10.

Horton MR, Shapiro S, Bao C et al (1999) Induction and regulation of macrophage metalloelastase by hyaluronan fragments in mouse macrophages. J Immunol 162:4171–4176PubMed

11.

Termeer C, Benedix F, Sleeman J et al (2002) Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 195:99–111CrossRefPubMedPubMedCentral

12.

Ponta H, Sherman L, Herrlich PA (2003) CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4:33–45. https://doi.org/10.1038/nrm1004 CrossRefPubMed

13.

Lawrence T, Natoli G (2011) Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 11:750–761. https://doi.org/10.1038/nri3088 CrossRefPubMed

14.

Kuang DM, Wu Y, Chen N et al (2007) Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes. Blood 110:587–595. https://doi.org/10.1182/blood-2007-01-068031 CrossRefPubMed

15.

Rayahin JE, Buhrman JS, Zhang Y et al (2015) High and low molecular weight hyaluronic acid differentially influence macrophage activation. ACS Biomater Sci Eng 1:481–493. https://doi.org/10.1021/acsbiomaterials.5b00181 CrossRefPubMedPubMedCentral

16.

Weigel PH, Baggenstoss BA (2017) What is special about 200 kDa hyaluronan that activates hyaluronan receptor signaling? Glycobiology 27:868–877. https://doi.org/10.1093/glycob/cwx039 CrossRefPubMedPubMedCentral

17.

Sokolowska M, Chen LY, Eberlein M et al (2014) Low molecular weight hyaluronan activates cytosolic phospholipase A2alpha and eicosanoid production in monocytes and macrophages. J Biol Chem 289:4470–4488. https://doi.org/10.1074/jbc.M113.515106 CrossRefPubMed

18.

Yamawaki H, Hirohata S, Miyoshi T et al (2009) Hyaluronan receptors involved in cytokine induction in monocytes. Glycobiology 19:83–92. https://doi.org/10.1093/glycob/cwn109 CrossRefPubMed

19.

Gordon S, Martinez FO (2010) Alternative activation of macrophages: mechanism and functions. Immunity 32:593–604. https://doi.org/10.1016/j.immuni.2010.05.007 CrossRefPubMed

20.

Ruffell D, Mourkioti F, Gambardella A et al (2009) A CREB-C/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair. Proc Natl Acad Sci USA 106:17475–17480. https://doi.org/10.1073/pnas.0908641106 CrossRefPubMedPubMedCentral

21.

Cho IJ, Woo NR, Kim SG (2008) The identification of C/EBPbeta as a transcription factor necessary for the induction of MAPK phosphatase-1 by toll-like receptor-4 ligand. Arch Biochem Biophys 479:88–96. https://doi.org/10.1016/j.abb.2008.08.007 CrossRefPubMed

22.

Zhou D, Huang C, Lin Z et al (2014) Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways. Cell Signal 26:192–197. https://doi.org/10.1016/j.cellsig.2013.11.004 CrossRefPubMed

23.

Squadrito ML, Etzrodt M, De Palma M et al (2013) MicroRNA-mediated control of macrophages and its implications for cancer. Trends Immunol 34:350–359. https://doi.org/10.1016/j.it.2013.02.003 CrossRefPubMedPubMedCentral

24.

Graff JW, Dickson AM, Clay G et al (2012) Identifying functional microRNAs in macrophages with polarized phenotypes. J Biol Chem 287:21816–21825. https://doi.org/10.1074/jbc.M111.327031 CrossRefPubMedPubMedCentral

25.

Cai X, Yin Y, Li N et al (2012) Re-polarization of tumor-associated macrophages to pro-inflammatory M1 macrophages by microRNA-155. J Mol Cell Biol 4:341–343. https://doi.org/10.1093/jmcb/mjs044 CrossRefPubMed

26.

Su S, Zhao Q, He C et al (2015) miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program. Nat Commun 6:8523. https://doi.org/10.1038/ncomms9523 CrossRefPubMed

27.

Squadrito ML, Pucci F, Magri L et al (2012) miR-511-3p modulates genetic programs of tumor-associated macrophages. Cell Rep 1:141–154. https://doi.org/10.1016/j.celrep.2011.12.005 CrossRefPubMed

28.

Banerjee S, Xie N, Cui H et al (2013) MicroRNA let-7c regulates macrophage polarization. J Immunol 190:6542–6549. https://doi.org/10.4049/jimmunol.1202496 CrossRefPubMed

29.

Maharjan AS, Pilling D, Gomer RH (2011) High and low molecular weight hyaluronic acid differentially regulate human fibrocyte differentiation. PLoS One 6:e26078. https://doi.org/10.1371/journal.pone.0026078 CrossRefPubMedPubMedCentral

30.

Zhang G, Guo L, Yang C et al (2016) A novel role of breast cancer-derived hyaluronan on inducement of M2-like tumor-associated macrophages formation. Oncoimmunology 5:e1172154. https://doi.org/10.1080/2162402X.2016.1172154 CrossRefPubMedPubMedCentral

31.

Eigsti RL, Sudan B, Wilson ME et al (2014) Regulation of activation-associated microRNA accumulation rates during monocyte-to-macrophage differentiation. J Biol Chem 289:28433–28447. https://doi.org/10.1074/jbc.M114.599316 CrossRefPubMedPubMedCentral

32.

Baer C, Squadrito ML, Laoui D et al (2016) Suppression of microRNA activity amplifies IFN-gamma-induced macrophage activation and promotes anti-tumour immunity. Nat Cell Biol. https://doi.org/10.1038/ncb3371 CrossRefPubMed

33.

Yan C, Yu J, Kang W et al (2016) miR-935 suppresses gastric signet ring cell carcinoma tumorigenesis by targeting Notch1 expression. Biochem Biophys Res Commun 470:68–74. https://doi.org/10.1016/j.bbrc.2015.12.116 CrossRefPubMed

34.

Yang M, Cui G, Ding M et al (2016) miR-935 promotes gastric cancer cell proliferation by targeting SOX7. Biomed Pharmacother 79:153–158. https://doi.org/10.1016/j.biopha.2016.01.011 CrossRefPubMed

35.

Liu X, Li J, Yu Z et al (2017) miR-935 Promotes Liver Cancer Cell Proliferation and Migration by Targeting SOX7. Oncol Res 25:427–435. https://doi.org/10.3727/096504016X14747300207374 CrossRefPubMedPubMedCentral

36.

Carter JV, Galbraith NJ, Yang D et al (2017) Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis. Br J Cancer 116:762–774. https://doi.org/10.1038/bjc.2017.12 CrossRefPubMedPubMedCentral

37.

Chauhan R, Lahiri N (2016) Tissue- and serum-associated biomarkers of hepatocellular carcinoma. Biomark Cancer 8:37–55. https://doi.org/10.4137/BIC.S34413 CrossRefPubMedPubMedCentral

38.

Nakamura K, Sawada K, Yoshimura A et al (2016) Clinical relevance of circulating cell-free microRNAs in ovarian cancer. Mol Cancer 15:48. https://doi.org/10.1186/s12943-016-0536-0 CrossRefPubMedPubMedCentral

Titel: INT-HA induces M2-like macrophage differentiation of human monocytes via TLR4-miR-935 pathway
verfasst von: Boke Zhang
Yan Du
Yiqing He
Yiwen Liu
Guoliang Zhang
Cuixia Yang
Feng Gao
Publikationsdatum: 19.10.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Cancer Immunology, Immunotherapy / Ausgabe 2/2019
Print ISSN: 0340-7004
Elektronische ISSN: 1432-0851
DOI: https://doi.org/10.1007/s00262-018-2261-6

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

INT-HA induces M2-like macrophage differentiation of human monocytes via TLR4-miR-935 pathway

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy

Hyperresponsiveness to interferon gamma exposure as a response mechanism to anti-PD-1 therapy in microsatellite instability colorectal cancer

Targeting the polarization of tumor-associated macrophages and modulating mir-155 expression might be a new approach to treat diffuse large B-cell lymphoma of the elderly

Tumor-infiltrating immune cell subpopulations and programmed death ligand 1 (PD-L1) expression associated with clinicopathological and prognostic parameters in ependymoma

Upregulation of tumor PD-L1 by neoadjuvant chemoradiotherapy (neoCRT) confers improved survival in patients with lymph node metastasis of locally advanced rectal cancers

Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinoma

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie